CLRB
Cellectar Biosciences, Inc.
+0.05 (+2.13%)2.40USD28.6K成交股數22.7M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 4.6M | 3.0M | 3.2M | 2.5M | 2.4M | 3.4M | 5.5M | 7.3M | 7.1M | 7.7M | 7.0M | 6.1M |
| 銷售管理費用 | 2.6M | 2.8M | 2.5M | 2.3M | 3.6M | 3.0M | 7.8M | 6.4M | 4.9M | 4.8M | 2.4M | 2.2M |
| 營業利益 | −7.2M+19% | −5.8M-9% | −5.7M-57% | −4.9M-65% | −6.0M-50% | −6.4M-49% | −13.3M+42% | −13.7M+65% | −12.0M | −12.5M | −9.4M | −8.3M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −6.9M+27% | −5.7M-14% | −5.3M-64% | −4.4M+383% | −5.4M-80% | −6.6M+113% | −14.7M-16% | −919K-91% | −26.6M | −3.1M | −17.5M | −10.2M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.57-83% | -1.33-69% | 0.75-106% | -1.41-74% | -3.39+273% | -4.30+949% | -12.13+683% | -5.43+503% | -0.91 | -0.41 | -1.55 | -0.90 |
| 稀釋股數 | 12.2M | 4.2M | 2.6M | 3.2M | 1.6M | 1.5M | 1.3M | 1.2M | 29.3M | 12.2M | 11.3M | 11.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 34.0M | 8.3M | 13.2M | 12.6M | 11.0M | 13.9M | 34.3M | 25.9M | 40.0M | 9.6M | 19.0M | 5.2M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 36.6M | 11.1M | 15.0M | 14.6M | 13.7M | 16.0M | 37.3M | 29.4M | 42.9M | 12.1M | 21.6M | 6.5M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 6.8M | 6.4M | 5.1M | 5.2M | 6.2M | 6.4M | 20.7M | 15.6M | 29.0M | 25.9M | 30.3M | 13.5M |
| 股東權益 | 29.9M | 3.3M | 8.5M | 8.0M | 6.1M | 8.3M | 15.2M | 12.4M | 12.5M | −15.2M | −28.0M | −8.4M |
| 負債比 | 18.5% | 57.6% | 33.8% | 35.9% | 45.5% | 39.9% | 55.6% | 53.2% | 67.6% | 214.1% | 140.8% | 207.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −4.8M-48% | – | – | – | −9.4M | – | – | −13.4M | – | – | – |
| 資本支出 | – | 3K | – | – | – | – | – | – | 22K | – | – | – |
| 自由現金流 | – | −4.8M | – | – | – | – | – | – | −13.4M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | 56K | – | – | 88K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −21.8M | –% | -8.35 | −23.1M |
| FY2024 | – | – | −44.6M | –% | -41.89 | −47.7M |
| FY2023 | – | – | −38.0M | –% | -3.50 | −33.2M |
| FY2022 | – | – | −31.8M | –% | -4.51 | −25.4M |
| FY2021 | – | – | −24.1M | –% | -4.35 | −22.7M |
| FY2020 | – | – | −15.1M | –% | -1.84 | −14.0M |
| FY2019 | – | – | −14.1M | –% | -1.84 | −11.7M |
| FY2018 | – | – | −13.2M | –% | -5.23 | −11.8M |